Approval Year
| Substance Class |
Protein
Created
by
admin
on
Edited
Sat Dec 16 07:01:18 GMT 2023
by
admin
on
Sat Dec 16 07:01:18 GMT 2023
|
| Protein Type | MONOCLONAL ANTIBODY |
| Protein Sub Type | IGG1 |
| Sequence Origin | HUMANIZED MOUSE |
| Sequence Type | COMPLETE |
| Record UNII |
DEW6X41BEK
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Related Record | Type |
|---|
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NDF-RT |
N0000192799
Created by
admin on Sat Dec 16 07:01:18 GMT 2023 , Edited by admin on Sat Dec 16 07:01:18 GMT 2023
|
||
|
NCI_THESAURUS |
C20401
Created by
admin on Sat Dec 16 07:01:18 GMT 2023 , Edited by admin on Sat Dec 16 07:01:18 GMT 2023
|
||
|
WHO-ATC |
L04AC17
Created by
admin on Sat Dec 16 07:01:18 GMT 2023 , Edited by admin on Sat Dec 16 07:01:18 GMT 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
CHEMBL2108681
Created by
admin on Sat Dec 16 07:01:18 GMT 2023 , Edited by admin on Sat Dec 16 07:01:18 GMT 2023
|
PRIMARY | |||
|
ZZ-43
Created by
admin on Sat Dec 16 07:01:18 GMT 2023 , Edited by admin on Sat Dec 16 07:01:18 GMT 2023
|
PRIMARY | |||
|
Tildrakizumab
Created by
admin on Sat Dec 16 07:01:18 GMT 2023 , Edited by admin on Sat Dec 16 07:01:18 GMT 2023
|
PRIMARY | |||
|
1326244-10-3
Created by
admin on Sat Dec 16 07:01:18 GMT 2023 , Edited by admin on Sat Dec 16 07:01:18 GMT 2023
|
PRIMARY | |||
|
5281
Created by
admin on Sat Dec 16 07:01:18 GMT 2023 , Edited by admin on Sat Dec 16 07:01:18 GMT 2023
|
PRIMARY | |||
|
m12075
Created by
admin on Sat Dec 16 07:01:18 GMT 2023 , Edited by admin on Sat Dec 16 07:01:18 GMT 2023
|
PRIMARY | |||
|
DB14004
Created by
admin on Sat Dec 16 07:01:18 GMT 2023 , Edited by admin on Sat Dec 16 07:01:18 GMT 2023
|
PRIMARY | |||
|
SUB130334
Created by
admin on Sat Dec 16 07:01:18 GMT 2023 , Edited by admin on Sat Dec 16 07:01:18 GMT 2023
|
PRIMARY | |||
|
DEW6X41BEK
Created by
admin on Sat Dec 16 07:01:18 GMT 2023 , Edited by admin on Sat Dec 16 07:01:18 GMT 2023
|
PRIMARY | |||
|
C152627
Created by
admin on Sat Dec 16 07:01:18 GMT 2023 , Edited by admin on Sat Dec 16 07:01:18 GMT 2023
|
PRIMARY | |||
|
DEW6X41BEK
Created by
admin on Sat Dec 16 07:01:18 GMT 2023 , Edited by admin on Sat Dec 16 07:01:18 GMT 2023
|
PRIMARY | |||
|
2053436
Created by
admin on Sat Dec 16 07:01:18 GMT 2023 , Edited by admin on Sat Dec 16 07:01:18 GMT 2023
|
PRIMARY | |||
|
Tildrakizumab
Created by
admin on Sat Dec 16 07:01:18 GMT 2023 , Edited by admin on Sat Dec 16 07:01:18 GMT 2023
|
PRIMARY | |||
|
2053449
Created by
admin on Sat Dec 16 07:01:18 GMT 2023 , Edited by admin on Sat Dec 16 07:01:18 GMT 2023
|
ALTERNATIVE | |||
|
100000156428
Created by
admin on Sat Dec 16 07:01:18 GMT 2023 , Edited by admin on Sat Dec 16 07:01:18 GMT 2023
|
PRIMARY | |||
|
9672
Created by
admin on Sat Dec 16 07:01:18 GMT 2023 , Edited by admin on Sat Dec 16 07:01:18 GMT 2023
|
PRIMARY |
| From | To |
|---|---|
| 1_22 | 1_96 |
| 1_143 | 1_199 |
| 1_260 | 1_320 |
| 1_366 | 1_424 |
| 2_22 | 2_96 |
| 2_143 | 2_199 |
| 2_260 | 2_320 |
| 2_366 | 2_424 |
| 3_23 | 3_88 |
| 3_134 | 3_194 |
| 4_23 | 4_88 |
| 4_134 | 4_194 |
| 1_219 | 3_214 |
| 2_219 | 4_214 |
| 1_225 | 2_225 |
| 1_228 | 2_228 |
| Glycosylation Link Type | Site |
|---|---|
| N | 1_296 |
| N | 2_296 |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
SUB_CONCEPT->SUBSTANCE |
|
||
|
TARGET -> INHIBITOR | |||
|
|
INNOVATOR->PARENT |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
| Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
|---|---|---|---|---|---|---|
| Molecular Formula | CHEMICAL |
|
||||
| MOL_WEIGHT:NUMBER(CALCULATED) | CHEMICAL |
|